Table 2.

Cancer Treatment and COVID-19 Outcomes

Patient	Planned RT Dose (Gy)	RT Dose Completed	Chemotherapy	COVID-19 Symptoms	Hospitalized	Overall Patient Outcome
1 (Kirakli et al.12)	20	0	None	None	Yes	CT findings before starting RT, asymptomatic but hospitalized owing to local policy, symptoms 48 h after CT simulation, discharged from hospital after 20 d
2	60	60	Carboplatin, paclitaxel	Fever, cough	Yes	Completed RT as inpatient, chemotherapy held after COVID-19 diagnosis, discharged from hospital after 2 consecutive negative tests
3	60	46	Carboplatin, paclitaxel	None	Yes	Admitted for neutropenia and esophagitis (not COVID-19), oncology treatment resumed as an inpatient, additional COVID-19 exposure while hospitalized, death from COVID-19
4	55	50	Cisplatin, pemetrexed	Fever	Yes	Recovered
5	66	24	Cisplatin, pemetrexed	Fever, cough, loss of smell/taste	Yes	RT interrupted, 4 wk hospitalization with severe illness at the time of submission
6	60	38	Cisplatin, etoposide	Fever	No	Self-isolating at home
7	60	60	Carboplatin, etoposide	Fever, cough	Yes	Completed RT 4 d before COVID-19 diagnosis, discharged to rehabilitation facility after 5 d, 2 negative tests 1 mo after
8 (Suppli et al.9)	60	18	Platinum doublet	Fever, cough, fatigue, myalgia	Yes	Death from respiratory failure 6 d after symptoms
9 (McGinnis et al.10)	50	50	None	None	No	Asymptomatic, completed SABR

COVID-19, coronavirus disease 2019; CT, computed tomography; RT, radiotherapy; SABR, stereotactic ablative radiotherapy.